Literature DB >> 34129840

A PGE2-MEF2A axis enables context-dependent control of inflammatory gene expression.

Francesco Cilenti1, Giulia Barbiera2, Nicoletta Caronni2, Dario Iodice2, Elisa Montaldo2, Simona Barresi2, Eleonora Lusito2, Vincenzo Cuzzola2, Francesco Maria Vittoria1, Luca Mezzanzanica1, Paolo Miotto3, Pietro Di Lucia4, Dejan Lazarevic5, Daniela Maria Cirillo3, Matteo Iannacone6, Marco Genua2, Renato Ostuni7.   

Abstract

Tight control of inflammatory gene expression by antagonistic environmental cues is key to ensure immune protection while preventing tissue damage. Prostaglandin E2 (PGE2) modulates macrophage activation during homeostasis and disease, but the underlying mechanisms remain incompletely characterized. Here we dissected the genomic properties of lipopolysaccharide (LPS)-induced genes whose expression is antagonized by PGE2. The latter molecule targeted a set of inflammatory gene enhancers that, already in unstimulated macrophages, displayed poorly permissive chromatin organization and were marked by the transcription factor myocyte enhancer factor 2A (MEF2A). Deletion of MEF2A phenocopied PGE2 treatment and abolished type I interferon (IFN I) induction upon exposure to innate immune stimuli. Mechanistically, PGE2 interfered with LPS-mediated activation of ERK5, a known transcriptional partner of MEF2. This study highlights principles of plasticity and adaptation in cells exposed to a complex environment and uncovers a transcriptional circuit for IFN I induction with relevance for infectious diseases or cancer.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LPS; MEF2; PGE2; chromatin; cytokines; inflammation; innate immunity; interferons; macrophages; transcription

Year:  2021        PMID: 34129840     DOI: 10.1016/j.immuni.2021.05.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  5 in total

1.  External signals regulate continuous transcriptional states in hematopoietic stem cells.

Authors:  Eva M Fast; Audrey Sporrij; Margot Manning; Edroaldo Lummertz Rocha; Song Yang; Yi Zhou; Jimin Guo; Ninib Baryawno; Nikolaos Barkas; David Scadden; Fernando Camargo; Leonard I Zon
Journal:  Elife       Date:  2021-12-23       Impact factor: 8.140

2.  Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs.

Authors:  Anna Eisenstein; Brandon K Hilliard; Scott D Pope; Cuiling Zhang; Pranali Taskar; Daniel A Waizman; Kavita Israni-Winger; Hui Tian; Harding H Luan; Andrew Wang
Journal:  Immunity       Date:  2022-05-18       Impact factor: 43.474

3.  MEF2C promotes M1 macrophage polarization and Th1 responses.

Authors:  Xibao Zhao; Qianqian Di; Han Liu; Jiazheng Quan; Jing Ling; Zizhao Zhao; Yue Xiao; Han Wu; Zherui Wu; Wengang Song; Huazhang An; Weilin Chen
Journal:  Cell Mol Immunol       Date:  2022-02-22       Impact factor: 22.096

4.  4-Octyl-Itaconate and Dimethyl Fumarate Inhibit COX2 Expression and Prostaglandin Production in Macrophages.

Authors:  Ciana Diskin; Alessia Zotta; Sarah E Corcoran; Victoria J Tyrrell; Zbigniew Zaslona; Valerie B O'Donnell; Luke A J O'Neill
Journal:  J Immunol       Date:  2021-10-11       Impact factor: 5.426

5.  Transcriptomic analysis shows that surgical treatment is likely to influence the endometrial receptivity of patients with stage III/IV endometriosis.

Authors:  Rui Xiang; Peigen Chen; Zhi Zeng; Huijun Liu; Juan Zhou; Chuanchuan Zhou; Jintao Peng; Haitao Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.